Skip to content

Overall Effectiveness Evaluation of the Blood Pressure Monitor (Arm type)

Overall Effectiveness Evaluation of the Blood Pressure Monitor (Arm type)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108636
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-05
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Gold Standard:Stethoscope-type sphygmomanometer for measuring blood pressure
Index test:Blood Pressure Monitor (Arm type)

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age > 12 years and gender is not limited; 2.Arm circumference of 22cm to 45cm (including the cut-off); 3.Voluntarily participate in blood pressure measurement and sign the informed consent form; 4.Be able to communicate well with the investigators, have good compliance, and follow the requirements of clinical research.

Exclusion criteria

Exclusion criteria: 1.The women who are or may be pregnant; 2. Patients with implanted, electrical devices, such as cardiac pacemakers,defifibrillators; 3. Patients with other conditions that may affect blood pressure measurement readings,such as atrial fibrillation, diabetes, etc.; 4.A subject is used repeatedly in a clinical investigation; 5.Persons with impaired consciousness cannot be adequately informed; 6.Other reasons that the investigators consider the person is not eligible for the research.

Design outcomes

Primary

MeasureTime frame
blood pressure measurement accuracy.;

Secondary

MeasureTime frame
pulse rate measurement accuracy;device performance evaluation;device defects;

Countries

China

Contacts

Public ContactZhang Li

Hebei General Hospital

1136329347@qq.com+86 132 4934 6346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026